Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C

Gastroenterology

Volumn 141, Issue 1, 2011, Pages

  Honda, Masao ^a   Takehana, Kenji ^b   Sakai, Akito ^a   Tagata, Yusuke ^b   Shirasaki, Takayoshi ^a   Nishitani, Shinobu ^b   Muramatsu, Takahiko ^c   Yamashita, Tatsuya ^a   Nakamoto, Yasunari ^a   Mizukoshi, Eishiro ^a   Sakai, Yoshio ^a   Yamashita, Taro ^a   Nakamura, Mikiko ^a   Shimakami, Tetsuro ^d   Yi, Minkyung ^e   Lemon, Stanley M ^d   Suzuki, Tetsuo ^f   Wakita, Takaji ^f   Kaneko, Shuichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b Mamezou Co Ltd   (Japan)

^c AJINOMOTO CO INC   (Japan)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

^f NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Diet; HCV; Liver Disease; Therapy

Indexed keywords

AMINO ACID; BRANCHED CHAIN AMINO ACID; INTERLEUKIN 28B; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PEGINTERFERON; RIBAVIRIN; TRANSCRIPTION FACTOR FOXO;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MASS SPECTROMETRY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; VIRUS LOAD;

EID: 79959982939     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.03.051     Document Type: Article

References (23)

1. M.W. Fried, M.L. Shiffman, and K.R. Reddy Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
2. Y. Tanaka, N. Nishida, and M. Sugiyama Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
3. D. Ge, J. Fellay, and A.J. Thompson Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
4. M. Honda, A. Sakai, and T. Yamashita Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C Gastroenterology 139 2010 499 509
5. A.J. Thompson, A.J. Muir, and M.S. Sulkowski Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus Gastroenterology 139 2010 120 129 e18
6. S. Nishitani, C. Ijichi, and K. Takehana Pharmacological activities of branched-chain amino acids: specificity of tissue and signal transduction Biochem Biophys Res Commun 313 2004 387 389 (Pubitemid 37543597)
7. T. Matsumura, Y. Morinaga, and S. Fujitani Oral administration of branched-chain amino acids activates the mTOR signal in cirrhotic rat liver Hepatol Res 33 2005 27 32 (Pubitemid 41447880)
8. D.H. Kim, D.D. Sarbassov, and S.M. Ali mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery Cell 110 2002 163 175 (Pubitemid 34876545)
9. R. Colina, M. Costa-Mattioli, and R.J. Dowling Translational control of the innate immune response through IRF-7 Nature 452 2008 323 328 (Pubitemid 351430792)
10. S. Kaur, L. Lal, and A. Sassano Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling J Biol Chem 282 2007 1757 1768 (Pubitemid 47076718)
11. K. Shimbo, S. Kubo, and Y. Harada Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography/mass spectrometry Biomed Chromatogr 24 2009 683 691
12. T. Shirasaki, M. Honda, and H. Mizuno La protein required for internal ribosome entry site-directed translation is a potential therapeutic target for hepatitis C virus replication J Infect Dis 202 2010 75 85
13. M. Yi, R.A. Villanueva, and D.L. Thomas Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells Proc Natl Acad Sci U S A 103 2006 2310 2315 (Pubitemid 43271666)
14. T. Shimakami, C. Welsch, and D. Yamane Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus Gastroenterology 140 2011 667 675
15. A. Eden, G. Simchen, and N. Benvenisty Two yeast homologs of ECA39, a target for c-Myc regulation, code for cytosolic and mitochondrial branched-chain amino acid aminotransferases J Biol Chem 271 1996 20242 22045
16. R.J. Dowling, I. Topisirovic, and T. Alain mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs Science 328 2010 1172 1176
17. A.A. Teleman, V. Hietakangas, and A.C. Sayadian Nutritional control of protein biosynthetic capacity by insulin via Myc in Drosophila Cell Metab 7 2008 21 32
18. X. Zhang, L. Gan, and H. Pan Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding J Biol Chem 277 2002 45276 45284 (Pubitemid 36159133)
19. F. Farinati, R. Cardin, and M. Bortolami Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis World J Gastroenterol 12 2006 2065 2069
20. K. Shimbo, S. Kubo, and Y. Harada Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography/mass spectrometry Biomed Chromatogr 24 2009 683 691
21. M. Yi, R.A. Villanueva, and D.L. Thomas Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells Proc Natl Acad Sci U S A 103 2006 2310 2315 (Pubitemid 43271666)
22. S. Shetty, S. Kim, and T. Shimakami Hepatitis C virus genomic RNA dimerization is mediated via a kissing complex intermediate RNA 16 2010 913 925
23. T. Shimakami, C. Welsch, and D. Yamane Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus Gastroenterology 140 2011 667 675